Skip to main content
. 2015 Jun 5;5(6):e007527. doi: 10.1136/bmjopen-2014-007527

FigureĀ 4.

FigureĀ 4

Sensitivity analysis: mean best corrected visual acuity (BCVA) letters gained from baseline for ranibizumab monotherapy over aflibercept.